Mark Pulido

Mark is a 5 time CEO & industry veteran with 4+ decades of leadership experience spanning Health IT, Health Services, Big Pharma, Diagnostics, Private Equity, & Venture Back Startups.

He is the former President & CEO @ ABILITY, a national leader in cloud-based solutions for the healthcare provider marketplace acquired for $1.2B by Inovalon in 2018. Mark served on the Board of Directors of Inovalon up until the company’s recent $7.2B acquisition.

Prior to his role at ABILITY, Mark focused on private equity and investing initiatives as an industry executive at Freeman Spogli. Previously he served as President & Chief Executive Officer @ BenefitPoint, an early stage Sequoia capital-backed employee benefits technology company.

Prior to that, he led several of the most prominent healthcare and information technology companies in the world. Mark served as President & CEO @ McKesson Corporation, a Fortune 10 healthcare services and information technology company; President & Chief Executive Officer @ Novartis Pharmaceuticals Corporation, USA (formerly Sandoz), a research-based pharmaceutical manufacturer; and Chairman, President & CEO @ Red Line Healthcare Corporation, a specialty long-term care distribution and medical billing company. He also served as Chairman of the Board of Directors @ Quidel, a manufacturer of diagnostic testing solutions and as a Board Member of several healthcare and technology companies, including Sunrise Medical, a medical equipment manufacturer; Smile Brands Group, a dental practice management company; Charles Schwab, a financial services company; and Imation, a technology company.

Outside of work, you can find Mark pursuing his passion for wine making at Pulido~Walker Cellars and supporting the community through Pulido~Walker Foundation focusing on education for youth at risk.